Cell Cryopreservation Market Expansion 2024-2033: Growth Drivers and Dynamics

The cell cryopreservation global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Cell Cryopreservation Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The cell cryopreservation market size has grown exponentially in recent years. It will grow from $10.21 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 23.8%. The growth in the historic period can be attributed to increasing demand for cell-based therapies, rise in biomedical research, growing need for organ transplantation, rise in R&D activities for cell based therapies and increasing use of cryopreserved cell.

The cell cryopreservation market size is expected to see exponential growth in the next few years. It will grow to $29.9 billion in 2028 at a compound annual growth rate (CAGR) of 24%. The growth in the forecast period can be attributed to rising demand for in vitro fertilization (IVF) procedures, advancement in organ transplantation procedures, expansion of biobanking activities, rising incidence of chronic diseases and positive government initiatives and funding. Major trends in the forecast period include advancements in cryopreservation techniques, advancements in MRNA vaccine storage and transportation, advancements in cryoprotectants and freezing techniques, growing trend towards personalized medicine and advancements in stem cell research.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cell-cryopreservation-global-market-report

Scope Of Cell Cryopreservation Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Cell Cryopreservation Market Overview

Market Drivers –
The increasing number of organ transplantation procedures is expected to propel the growth of the cell cryopreservation market going forward. Organ transplantation is a medical procedure where a damaged or failing organ is replaced with a healthy organ from a donor. Organ transplant procedures are increasing due to organ failure caused by hereditary abnormalities, infections, traumas, and chronic diseases. Cell cryopreservation in organ transplantation involves freezing and storing cells from organs to preserve their viability for future use, enhancing graft success, and reducing immune rejection. For instance, in January 2024, according to the Health Resources and Services Administration, a US-based federal agency, in 2023, there were 46,632 organ transplants performed from both living and deceased donors, marking an 8.7% increase from 2022 and a 12.7% increase from 2021, which was the first year with over 40,000 organ transplants. Therefore, increasing organ transplantation procedures are driving the growth of the cell cryopreservation market.

Market Trends –
Companies operating in the cell cryopreservation market focus on developing cryopreservation medium solutions to better serve customers with advanced features. Cryopreservation medium solution refers to specialized formulations that preserve cells or tissues by freezing them at ultra-low temperatures, facilitating long-term storage and transportation while maintaining viability and functionality. For instance, in April 2024, Pluristyx Inc., a US-based provider of tools, technologies, and services for cellular therapies, launched PluriFreeze, a proprietary cryopreservation medium solution to accelerate stem cell therapy development. This solution is developed to support the growth of induced pluripotent stem cells (iPSCs) and offers an innovative method to improve the efficiency and quality of iPSC therapy development. Pluristyx’s PluriFreeze Cryopreservation Media, intended for Research Use Only (RUO), aims to streamline the development of stem cell therapy and aid in commercializing cell therapies.

The cell cryopreservation market covered in this report is segmented –

1) By Product: Cell Freezing Media, Equipment, Consumables
2) By Application: Hepatocytes, Stem Cells, Oocytes And Embryotic cells, Sperm Cells, Other Applications
3) By End-Use Channel: Biopharmaceutical And Pharmaceutical Companies, Research Institutes, Biobanks, In Vitro Fertilization (IVF) Clinics, Other End-Use Channels

Get an inside scoop of the cell cryopreservation market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15755&type=smp

Regional Insights –
North America was the largest region in the cell cryopreservation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies –
Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., BioLife Solutions Inc, Nkarta Inc., Tn-Sanso Corporation, Coya Therapeutics, FUJIFILM Irvine Scientific, Artiva Biotherapeutics, Acorn Biolabs Inc., ThermoGenesis Holdings Inc., Evia Bio Inc., Wideblue Limited, Akron Biotech, Captivate Bio LLC, Pluristyx Inc., CryoCrate LLC, PanTHERA CryoSolutions, ParaTechs Corporation, Plus Therapeutics, X-Therma Inc., Protein Technologies Limited

Table of Contents
1. Executive Summary
2. Cell Cryopreservation Market Report Structure
3. Cell Cryopreservation Market Trends And Strategies
4. Cell Cryopreservation Market – Macro Economic Scenario
5. Global Cell Cryopreservation Market Size and Growth
.
.
.
32. Global Cell Cryopreservation Market Competitive Benchmarking
33. Global Cell Cryopreservation Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cell Cryopreservation Market
35. Cell Cryopreservation Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model